Which clinical feature best distinguishes Type A (dose-dependent) adverse drug reactions from Type B (idiosyncratic) adverse drug reactions?

Explanation

## Distinguishing Type A from Type B Adverse Drug Reactions ### Type A (Augmented) Reactions **Key Point:** Type A reactions are dose-dependent, predictable, and reproducible in animal models because they represent an exaggeration of the drug's known pharmacological action. - Occur at higher-than-therapeutic doses - Follow dose-response relationship - Reproducible in animal toxicity studies - Examples: Hypoglycemia from insulin overdose, bleeding from warfarin overdose - Account for ~80% of all ADRs ### Type B (Bizarre/Idiosyncratic) Reactions **Key Point:** Type B reactions are unpredictable, dose-independent, and NOT reproducible in animal models because they do not represent an extension of the drug's known pharmacology. - Occur at therapeutic or sub-therapeutic doses - No clear dose-response relationship - Cannot be reproduced in animal models - Often involve genetic factors (e.g., G6PD deficiency, slow acetylators, HLA associations) - Examples: Penicillin anaphylaxis, sulfonamide-induced Stevens-Johnson syndrome, chloramphenicol aplastic anemia - Account for ~20% of all ADRs ### Comparison Table | Feature | Type A (Augmented) | Type B (Idiosyncratic) | |---------|-------------------|------------------------| | **Dose-dependence** | Yes, predictable | No, unpredictable | | **Reproducibility** | Yes, in animal models | No, not reproducible | | **Pharmacological basis** | Extension of known action | Unrelated to known action | | **Frequency** | ~80% of ADRs | ~20% of ADRs | | **Genetic factors** | Not usually involved | Often involved | | **Onset** | Dose-related timing | Variable, often delayed | | **Examples** | Toxicity from overdose | Anaphylaxis, organ failure | **High-Yield:** The single best discriminator is the **dose-response relationship and reproducibility in animal models**. Type A is predictable and testable; Type B is not. **Clinical Pearl:** Type B reactions are more concerning clinically because they cannot be predicted by pre-clinical testing and often require immediate drug withdrawal and supportive care.